Involvement of claudin-1 in the β-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers

Oncology Research

Volumn 12, Issue 11-12, 2000, Pages 469-476

  Miwa, Nobutomo ^a,b   Furuse, Mikio ^c   Tsukita, Shoichiro ^c   Niikawa, Norio ^b   Nakamura, Yusuke ^a   Furukawa, Yoichi ^a,d  

^a UNIVERSITY OF TOKYO   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^d THE UNIVERSITY OF TOKYO   (Japan)

Author keywords

Claudin 1; Colon cancer; Tight junction; Wnt wingless signaling pathway; Catenin

Indexed keywords

BETA CATENIN; CLAUDIN 1; CTNNB1 PROTEIN, HUMAN; CYTOSKELETON PROTEIN; DNA BINDING PROTEIN; LYMPHOID ENHANCER FACTOR 1; MEMBRANE PROTEIN; PRIMER DNA; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL CULTURE; COLON; COLON TUMOR; CYTOLOGY; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMID; RECTUM TUMOR; REPORTER GENE; SIGNAL TRANSDUCTION; TIGHT JUNCTION;

BETA CATENIN; COLON; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; DNA PRIMERS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MEMBRANE PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PLASMIDS; RECTAL NEOPLASMS; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0034584636     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: 10.3727/096504001108747477     Document Type: Article

References (42)

1. Morin, P. J.; Sparks, A. B.; Korinek, V.; Barker, N.; Clevers, H.; Vogelstein, B.; Kinder, K. W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC [see comments]. Science 275:1787-1790; 1997.
2. Iwao, K.; Nakamori, S.; Kameyama, M.; Imaoka, S.; Kinoshita, M.; Fukui, T.; Ishiguro, S.; Nakamura, Y.; Miyoshi, Y. Activation of the beta-catenin gene by interstitial deletions involving exon 3 in primary colorectal carcinomas without adenomatous polyposis coli mutations. Cancer Res. 58:1021-1026; 1998.
3. Sparks, A. B.; Morin, P. J.; Vogelstein, B.; Kinzler, K. W. Mutational analysis of the APC/beta-catenin/Tcf pathway in colorectal cancer. Cancer Res. 58:1130-1134; 1998.
4. da Costa, L. T.; He, T. C.; Yu, J.; Sparks, A. B.; Morin, P. J.; Polyak, K.; Laken, S.; Vogelstein, B.; Kinzler, K. W. CDX2 is mutated in a colorectal cancer with normal APC/beta-catenin signaling. Oncogene 18:5010-5014; 1999.
5. Miyoshi, Y.; Iwao, K.; Nagasawa, Y.; Aihara, T.; Sasaki, Y.; Imaoka, S.; Murata, M.; Snimano, T.; Nakamura, Y. Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res. 58:2524-2527; 1998.
6. Fukuchi, T.; Sakamoto, M.; Tsuda, H.; Maruyama, K.; Nozawa, S.; Hirohashi, S. Beta-catenin mutation in carcinoma of the uterine endometrium. Cancer Res. 58:3526-3528; 1998.
7. Zurawel, R. H.; Chiappa, S. A.; Allen, C.; Raffel, C. Sporadic medulloblastomas contain oncogenic beta-catenin mutations. Cancer Res. 58:896-899; 1998.
8. Satoh, S.; Daigo, Y.; Furukawa, Y.; Kato, T.; Miwa, N.; Nishiwaki, T.; Kawasoe, T.; Ishiguro, H.; Fujita, M.; Tokino, T.; Sasaki, Y.; Imaoka, S.; Murata, M.; Shimano, T.; Yamaoka, Y.; Nakamura, Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat. Genet. 24:245-250; 2000.
9. Rubinfeld, B.; Albert, I.; Porfiri, E.; Fiol, C.; Munemitsu, S.; Polakis, P. Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science 272:1023-1026; 1995.
10. Yamamoto, H.; Kishida, S.; Kishida, M.; Ikeda, S.; Takada, S.; Kikuchi, A. Phosphorylation of axin, a Wnt signal negative regulator, by glycogen synthase kinase-3beta regulates its stability. J. Biol. Chem. 274:10681-10684; 1999.
11. Korinek, V.; Barker, N.; Morin, P. J.; van Wichen, D.; de Weger, R.; Kinzler, K. W.; Vogelstein, B.; Clevers, H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-l-colon carcinoma [see comments]. Science 275:1784-1787; 1997.
12. Rubinfeld, B.; Robbins, P.; El-Gamil, M.; Albert, I.; Porfiri, E.; Polakis, P. Stabilization of beta-catenin by genetic defects in melanoma cell lines [see comments]. Science 275:1790-1792; 1997.
13. Behrens, J.; von Kries, J. P.; Kuhl, M.; Bruhn, L.; Wedlich, D.; Grosschedl, R.; Birchmeier, W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature 382:-638-642; 1996.
14. He, T. C.; Sparks, A. B.; Rago, C.; Hermeking, H.; Zawel, L.; da Costa, L. T.; Morin, P. J.; Vogelstein, B.; Kinzler, K. W. Identification of c-MYC as a target of the APC pathway [see comments]. Science 281:1509-1512; 1998.
15. Pennica, D.; Swanson, T. A.; Welsh, J. W.; Roy, M. A.; Lawrence, D. A.; Lee, J.; Brush, J.; Taneyhill, L. A.; Deuel, B.; Lew, M.; Watanabe, C.; Cohen, R. L.; Melnem, M. F.; Finley, G. G.; Quirke, P.; Goddard, A. D.; Hillan, K. J.; Gurney, A. L.; Botstein, D.; Levine, A. J. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors. Proc. Natl. Acad. Sci. USA 95:14717-14722; 1998.
16. Tetsu, O.; McCormick, F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426; 1999.
17. Brabletz, T.; Jung, A.; Dag, S.; Hlubek, F.; Kirchner, T. Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155:1033-1038; 1999.
18. Crawford, H. C.; Fingleton, B. M.; Rudolph-Owen, L. A.; Goss, K. J.; Rubinfeld, B.; Polakis, P.; Matrisian, L. M. The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors. Oncogene 18:2883-2891; 1999.
19. Mann, B.; Gelos, M.; Siedow, A.; Hanski, M. L.; Gratchev, A.; Ilyas, M.; Bodrner, W. F.; Moyer, M. P.; Riecken, E. O.; Buhr, H. J.; Hanski, C. Target genes of beta-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas. Proc. Nad. Acad. Sci. USA 96:1603-1608; 1999.
20. Ishiguro, H.; Furukawa, Y.; Daigo, Y.; Miyoshi, Y.; Nagasawa, Y.; Nishiwab, T.; Kawasoe, T.; Fujita, M.; Satoh, S.; Miwa, N.; Fujii, Y.; Nakamura, Y. Isolation and characterization of human NBL4, a gene involved in the beta-catenin/tcf signaling pathway. Jpn. J. Cancer Res. 91:597-603; 2000.
21. Kawasoe, T.; Furukawa, Y.; Daigo, Y.; Nishiwaki, T.; Ishiguro, H.; Fujita, M.; Satoh, S.; Miwa, N.; Nagasawa, Y.; Miyoshi, Y.; Ogawa, M.; Nakamura, Y. Isolation and characterization of a novel human gene, DRCTNNB1A, the expression of which is down-regulated by beta-catenin. Cancer Res. 60:3354-3358; 2000.
22. Fujita, M.; Furukawa, Y.; Nagasawa, Y.; Ogawa, M.; Nakamura, Y. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Cancer Res. 60:6683-6687; 2000.
23. Furuse, M.; Sasaki, H.; Fujimoto, K.; and Tsukita, S. A single gene product, claudin-1 or -2, reconstitutes tight junction strands and recruits occludin in fibroblasts. J. Cell Biol. 143:391-401; 1998.
24. Furuse, M.; Fujita, K.; Hiiragi, T.; Fujimoto, K.; Tsukita, S. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 141:1539-1550; 1998.
25. Monta, K.; Furuse, M.; Fujimoto, K.; Tsukita, S. Qaudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. USA 96: 511-516; 1999.
26. Swisshelm, K.; Machl, A.; Planitzer, S.; Robertson, R.; Kubbies, M.; Hosier, S. SEMP1, a senescence-associated cDNA isolated from human mammary epithelial cells, is a member of an epithelial membrane protein superfamily. Gene 226:285-295; 1999.
27. Itoh, M.; Furuse, M.; Morita, K.; Kubota, K.; Saitou, M.; Tsukita, S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J. Cell Biol. 147:1351-1363; 1999.
28. Munemitsu, S.; Albert, I.; Souza, B.; Rubinfeld, B.; Polakis, P. Regulation of intracellular beta-catenin levels by the adcnomatous polyposis coli (APC) tumor-suppressor protein. Proc. Natl. Acad. Sci. USA 92:3046-3050; 1995.
29. McGrory, W. J.; Bautista, D. S.; Graham, F. L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163:614-617; 1988.
30. Ono, K.; Tanaka, T.; Tsunoda, T.; Kitahara, O.; Kihara, C.; Okamoto, A.; Ochiai, K.; Takagi, T.; Nakamura, Y. Identification by cDNA microarray of genes involved in ovarian carcinogenesis. Cancer Res. 60:5007-5011; 2000.
31. Moon, R. T.; Kimelman, D. From cortical rotation to organizer gene expression: Toward a molecular explanation of axis specification in Xenopus. Bioessays 20:536-545; 1998.
32. Takeichi, M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251:1451-1455; 1991.
33. van der Heyden, M. A.; Rook, M. B.; Hermans, M. M.; Rijksen, G.; Boonstra, J.; Defize, L. H.; Destree, O. H. Identification of connexin43 as a functional target for Wnt signalling. J. Cell Sci. 111:1741-1749; 1998.
34. Mimori-Kiyosue, Y.; Shiina, N.; Tsukita, S. Adenomatous polyposis coli (APC) protein moves along microtubules and concentrates at their growing ends in epithelial cells. J. Cell Biol. 148:505-518; 2000.
35. Nathke, I. S.; Adams, C. L.; Polakis, P.; Sellin, J. H.; Nelson, W. J. The adenomatous polyposis coli rumor suppressor protein localizes to plasma membrane sites involved in active cell migration. J. Cell Biol. 134:165-179; 1996.
36. Kawasaki, Y.; Senda, T.; Ishidate, T.; Koyama, R.; Morishita, T.; Iwayama, Y.; Higuchi, O.; Akiyama, T. Asef, a link between the tumor suppressor APC and G-protein signaling. Science 289: 1194-1197; 2000.
37. Anderson, J. M. Cell signalling: MAGUK magic. Curr. Biol. 6: 382-384; 1996.
38. Dimitratos, S. D.; Woods, D. F.; Stathakis, D. G.; Bryant, P. J. Signaling pathways are focused at specialized regions of the plasma membrane by scaffolding proteins of the MAGUK family. Bioessays 21:912-921; 1999.
39. Hoover, K. B.; Liao, S. Y.; Bryant, P. J. Loss of the tight junction MAGUK ZO-1 in breast cancer: Relationship to glandular differentiation and loss of heterozygosity. Am. J. Pathol. 153:1767-1773; 1998.
40. Mullin, J. M.; Soler, A. P.; Laughlin, K. V.; Kampherstein, J. A.; Russo, L. M.; Saladik, D. T.; George, K.; Shurina, R. D.; O'Brien, T. G. Chronic exposure of LLC-PK1 epithelia to the phorbol ester TPA produces polyp-like foci with leaky tight junctions and altered protein kinase C-alpha expression and localization. Exp. Cell Res. 227:12-22; 1996.
41. Soler, A. P.; Miller, R. D.; Laughlin, K. V.; Carp, N. Z.; Klurfeld, D. M.; Mullin, J. M. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 20:1425-1431; 1999.
42. Mullin, J. M. Potential interplay between luminal growth factors and increased tight junction permeability in epithelial carcinogenesis. J. Exp. Zool. 279:484-489; 1997.